Evaluation of Effect of Rifampin on the Pharmacokinetics of Vonoprazan in Healthy Participants
Clinical trial NCT04558216 · WITHDRAWN
Trial details
- NCT number
- NCT04558216
- Sponsor
- Phathom Pharmaceuticals, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-30
- Primary completion
- 2021-02-07
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.